Additionally, treatment with sorafenib largely blunted the transcriptional activities of MMP1 and MMP3 (p < 0.05, Fig. 5g), which are required to mediate cell invasion during wound repair and even tumor metastasis [35, 36]. The gene discussed is MMP3; the disease is neoplasm.